Clinical Trials in Portland

Showing 1721-1740 of 10,048 trials

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT04850599

This phase II trial studies the effect of isatuximab, carfilzomib, and pomalidomide in treating patients with multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory). Isatuximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as pomalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving isatuximab, carfilzomib, and pomalidomide may help treat patients with multiple myeloma.

Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma

OHSU Knight Cancer Institute5 participantsStarted Jun 2022

Portland, Oregon, United States

COMPLETEDPhase 3< 1 mile

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

NCT03009981

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.

Prostate Cancer

Alliance Foundation Trials, LLC.504 participantsStarted Mar 2017

Phoenix, Arizona, United States • Chula Vista, California, United States • Duarte, California, United States +66 more locations

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Find Trials by Condition in Portland

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Blue Light Cystoscopy With Cysview® Registry

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

SyncAV Post-Market Trial

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)